These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1252 related articles for article (PubMed ID: 25850553)

  • 1. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update.
    Takebe N; Miele L; Harris PJ; Jeong W; Bando H; Kahn M; Yang SX; Ivy SP
    Nat Rev Clin Oncol; 2015 Aug; 12(8):445-64. PubMed ID: 25850553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic target discovery and drug development in cancer stem cells for leukemia and lymphoma: from bench to the clinic.
    Laranjeira AB; Yang SX
    Expert Opin Drug Discov; 2016 Nov; 11(11):1071-1080. PubMed ID: 27626707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways.
    Takebe N; Harris PJ; Warren RQ; Ivy SP
    Nat Rev Clin Oncol; 2011 Feb; 8(2):97-106. PubMed ID: 21151206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eliminating Cancer Stem Cells by Targeting Embryonic Signaling Pathways.
    Oren O; Smith BD
    Stem Cell Rev Rep; 2017 Feb; 13(1):17-23. PubMed ID: 27730468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting stem cell signaling pathways for drug discovery: advances in the Notch and Wnt pathways.
    An SM; Ding Q; Zhang J; Xie J; Li L
    Sci China Life Sci; 2014 Jun; 57(6):575-80. PubMed ID: 24829106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Potential, Challenges and Future Perspective of Cancer Stem Cells in Translational Oncology: A Critical Review.
    Shukla G; Khera HK; Srivastava AK; Khare P; Patidar R; Saxena R
    Curr Stem Cell Res Ther; 2017; 12(3):207-224. PubMed ID: 27804866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update.
    Clara JA; Monge C; Yang Y; Takebe N
    Nat Rev Clin Oncol; 2020 Apr; 17(4):204-232. PubMed ID: 31792354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting pancreatic cancer stem cells for cancer therapy.
    Xia J; Chen C; Chen Z; Miele L; Sarkar FH; Wang Z
    Biochim Biophys Acta; 2012 Dec; 1826(2):385-99. PubMed ID: 22728049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Notch to target cancer stem cells.
    Pannuti A; Foreman K; Rizzo P; Osipo C; Golde T; Osborne B; Miele L
    Clin Cancer Res; 2010 Jun; 16(12):3141-52. PubMed ID: 20530696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Novel signal transduction pathways: the molecular basis for targeted cancer therapies in Hedgehog/Notch/Wnt pathway].
    Shimizu T; Nakagawa K
    Nihon Rinsho; 2015 Aug; 73(8):1342-8. PubMed ID: 26281688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors.
    Krishnamurthy N; Kurzrock R
    Cancer Treat Rev; 2018 Jan; 62():50-60. PubMed ID: 29169144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-Renewal and Pluripotency in Osteosarcoma Stem Cells' Chemoresistance: Notch, Hedgehog, and Wnt/β-Catenin Interplay with Embryonic Markers.
    Martins-Neves SR; Sampaio-Ribeiro G; Gomes CMF
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eradicating Cancer Stem Cells: Concepts, Issues, and Challenges.
    Kaur G; Sharma P; Dogra N; Singh S
    Curr Treat Options Oncol; 2018 Mar; 19(4):20. PubMed ID: 29556842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting crosstalk of signaling pathways in cancer stem cells: a promising approach for development of novel anti-cancer therapeutics.
    Bhal S; Kundu CN
    Med Oncol; 2023 Jan; 40(2):82. PubMed ID: 36662310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphogen pathways as molecular targets for the treatment of fibrosis in systemic sclerosis.
    Beyer C; Dees C; Distler JH
    Arch Dermatol Res; 2013 Jan; 305(1):1-8. PubMed ID: 23208311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug discovery approaches to target Wnt signaling in cancer stem cells.
    Curtin JC; Lorenzi MV
    Oncotarget; 2010 Nov; 1(7):563-577. PubMed ID: 21317452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and characterization of a potent Wnt and hedgehog signaling pathways dual inhibitor.
    Ma H; Chen Q; Zhu F; Zheng J; Li J; Zhang H; Chen S; Xing H; Luo L; Zheng LT; He S; Zhang X
    Eur J Med Chem; 2018 Apr; 149():110-121. PubMed ID: 29499483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch Signaling in Breast Cancer: A Role in Drug Resistance.
    BeLow M; Osipo C
    Cells; 2020 Sep; 9(10):. PubMed ID: 33003540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Small Molecule Inhibitors of Cancer Stem Cell Signaling Pathways.
    Abetov D; Mustapova Z; Saliev T; Bulanin D; Batyrbekov K; Gilman CP
    Stem Cell Rev Rep; 2015 Dec; 11(6):909-18. PubMed ID: 26210995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer stem cells.
    Yu Z; Pestell TG; Lisanti MP; Pestell RG
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2144-51. PubMed ID: 22981632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.